169 related articles for article (PubMed ID: 34143816)
21. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.
Toft L; Tolstrup M; Müller M; Sehr P; Bonde J; Storgaard M; Østergaard L; Søgaard OS
Hum Vaccin Immunother; 2014; 10(5):1147-54. PubMed ID: 24553190
[TBL] [Abstract][Full Text] [Related]
23. High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial.
Giuliano AR; Botha MH; Zeier M; Abrahamsen ME; Glashoff RH; van der Laan LE; Papenfuss M; Engelbrecht S; Schim van der Loeff MF; Sudenga SL; Torres BN; Kipping S; Taylor D
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):227-35. PubMed ID: 25415290
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial.
Six L; Leodolter S; Sings HL; Barr E; Haupt R; Joura EA
Wien Klin Wochenschr; 2008; 120(21-22):666-71. PubMed ID: 19116707
[TBL] [Abstract][Full Text] [Related]
25. A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.
Giambi C; Donati S; Carozzi F; Salmaso S; Declich S; Atti ML; Ronco G; Alibrandi MP; Brezzi S; Collina N; Franchi D; Lattanzi A; Minna MC; Nannini R; Barretta E; Burroni E; Gillio-Tos A; Macallini V; Pierotti P; Bella A
BMC Infect Dis; 2013 Feb; 13():74. PubMed ID: 23390953
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15-23 years.
Baudu A; Prétet JL; Riethmuller D; Chotard M; Mougin C; Mercier M
J Epidemiol Glob Health; 2014 Mar; 4(1):35-43. PubMed ID: 24534334
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus prevalence among unvaccinated young female college students in Botswana: A cross-sectional study.
Ramatlho P; Grover S; Mathoma A; Tawe L; Matlhagela K; Ngoni K; Molebatsi K; Chilisa B; Zetola NM; Robertson ES; Paganotti GM; Ramogola-Masire D
S Afr Med J; 2022 Apr; 112(5):335-340. PubMed ID: 35587246
[TBL] [Abstract][Full Text] [Related]
28. Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females.
Subasinghe AK; Wark JD; Phillips S; Cornall A; Brotherton JML; Garland SM
Sex Health; 2020 Dec; 17(6):510-516. PubMed ID: 33341122
[TBL] [Abstract][Full Text] [Related]
29. Human papillomaviruses in Western Africa: prevalences and risk factors in Burkina Faso.
Maria H; Dana H; Françoise M; Michael P; Jürgen W
Arch Gynecol Obstet; 2018 Oct; 298(4):789-796. PubMed ID: 30120545
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus genotypes in asymptomatic young women from public schools in Rio de Janeiro, Brazil.
Oliveira LH; Ferreira MD; Augusto EF; Melgaço FG; Santos LS; Cavalcanti SM; Rosa ML
Rev Soc Bras Med Trop; 2010; 43(1):4-8. PubMed ID: 20305959
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?
Panatto D; Amicizia D; Tanzi E; Bianchi S; Frati ER; Zotti CM; Lai PL; Bechini A; Rossi S; Gasparini R
BMC Infect Dis; 2013 Dec; 13():575. PubMed ID: 24313984
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and Genotypes of Human Papillomavirus among Men in Yunnan Province, China.
Xu Y; Zhang Y; Fan X; Zhang G; Dian Z; Sun Y
Jpn J Infect Dis; 2021 Jul; 74(4):280-284. PubMed ID: 33250493
[TBL] [Abstract][Full Text] [Related]
33. An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain.
Moosa K; Alsayyad AS; Quint W; Gopala K; DeAntonio R
BMC Cancer; 2014 Dec; 14():905. PubMed ID: 25466757
[TBL] [Abstract][Full Text] [Related]
34. DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.
Ermel AC; Shew ML; Weaver BA; Qadadri B; Denski C; Tu W; Tong Y; Fortenberry JD; Brown DR
Sex Transm Infect; 2014 Feb; 90(1):64-9. PubMed ID: 24031030
[TBL] [Abstract][Full Text] [Related]
35. Vaccine Hesitancy Drives Low Human Papillomavirus Vaccination Coverage in Girls Attending Public Schools in South Africa.
Khosa LA; Meyer JC; Motshwane FMM; Dochez C; Burnett RJ
Front Public Health; 2022; 10():860809. PubMed ID: 35685759
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of genital human papillomavirus DNA in a sample of senior school-aged women in the Australian Capital Territory.
O'Keefe EJ; Gardner A; Currie MJ; Garland S; Tabrizi S; Bowden FJ
Sex Health; 2006 May; 3(2):91-4. PubMed ID: 16800394
[TBL] [Abstract][Full Text] [Related]
37. Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.
Menezes LJ; Pokharel U; Sudenga SL; Botha MH; Zeier M; Abrahamsen ME; Glashoff RH; Engelbrecht S; Schim van der Loeff MF; van der Laan LE; Kipping S; Taylor D; Giuliano AR
Sex Transm Infect; 2018 Feb; 94(1):55-61. PubMed ID: 28490581
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012-2018: baseline measures prior to mass HPV vaccination.
Luo LP; He P; Liu QT; Jiang YH; Zhang YN; Li QZ; Li Q; Li ST; Yang F; Ling H; Dai XG; Li ZY; Chen HL
BMC Infect Dis; 2021 Apr; 21(1):328. PubMed ID: 33827456
[TBL] [Abstract][Full Text] [Related]
39. Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England.
Mesher D; Soldan K; Howell-Jones R; Panwar K; Manyenga P; Jit M; Beddows S; Gill ON
Vaccine; 2013 Dec; 32(1):26-32. PubMed ID: 24211166
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.
Einstein MH; Baron M; Levin MJ; Chatterjee A; Edwards RP; Zepp F; Carletti I; Dessy FJ; Trofa AF; Schuind A; Dubin G;
Hum Vaccin; 2009 Oct; 5(10):705-19. PubMed ID: 19684472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
